Free Access
Med Sci (Paris)
Volume 31, Number 2, Février 2015
Page(s) 209 - 213
Section Forum
Published online 04 March 2015
  1. Cassier M, Stoppa-Lyonnet D. L’opposition contre les brevets de Myriad Genetics et leur invalidation totale ou partielle en Europe. Premiers enseignements. Med/Sci (Paris) 2005 ; 21 : 658–662. [Google Scholar]
  2. Eisenberg R. The move toward the privatization of biomedical research. in C Barfield, Smith BLR, eds. The future of biomedical research. Washington DC : American Entreprise Institute, 1997 : 121–124. [Google Scholar]
  3. Cassier M, Stoppa-Lyonnet D. Un juge fédéral et le gouvernement des États-Unis interviennent contre la brevetabilité des gènes. Med Sci (Paris) 2011 ; 27 : 662–666. [Google Scholar]
  4. Sulston J, Ferry G. The common thread. A story of science, politics, ethics and the human genome. Washington : Joseph Henry Press, 2002. [Google Scholar]
  5. Calvert J, Joly PB. How did the gene become a chemical compound ? The ontology of the gene and the patenting of DNA. Social Science Information 2011 ; 50 : 157–177. [CrossRef] [Google Scholar]
  6. Cook-Deegan R, Conley JM, Evans JP, Vorhaus D. The next controversy in genetic testing: clinical data as trade secrets ? Eur J Hum Genet 2013 ; 21 : 585–588. [CrossRef] [PubMed] [Google Scholar]
  7. Van Overwalle G. Turning patent swords into shares. Science 2010 ; 330 : 1630–1631. [CrossRef] [PubMed] [Google Scholar]
  8. Hopkins M, Hoggart. Biomarkers patents for diagnostics. Problem or solution ? Nat Biotechnol 2012 ; 30 : 498–500. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.